DarioHealth (DRIO) Tops Q3 EPS by 12c

DarioHealth (NASDAQ: DRIO) reported Q3 EPS of ($0.64), $0.12 better than the analyst estimate of ($0.76). Revenue for the quarter came in at $6.61 million versus the consensus estimate of $6.29 million.

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79